Bright Green (Bright Green) Momentum Rank : 0 (As of May. 16, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Bright Green Momentum Rank?

Bright Green has the Momentum Rank of 0.

For Momentum Rank, we considered the residual momentum concept that was widely studied by Blitz and his colleagues as well as by Nobel Prize laureates Fama and French. However, we did not find any significant differences in the performances of stocks with different ranks of residual momentum. Therefore, we use traditional momentum instead.

Momentum Rank is determined using the standardized momentum ratio and other momentum indicators. The standardized momentum ratio is the average of the performances from 12 months ago to 1 month ago and 6 months ago to 1 month ago, divided by the beta of the stock over the past 12 months. To calculate the momentum ratio today, we would use the average of the two performance numbers.

For momentum, we found that stock price performance does not have a monotonic correlation with the momentum ratio. The stocks with the highest momentum ratios perform worse than those at about the 70th percentile. Therefore, for the momentum rank, we ranked the stocks at about the 70th percentile of the momentum ratio as the highest at 10.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Bright Green Momentum Rank Related Terms

Thank you for viewing the detailed overview of Bright Green's Momentum Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Bright Green (Bright Green) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bright Green Corp (NAS:BGXX) » Definitions » Momentum Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

1033 George Hanosh Boulevard, Grants, NM, USA, 87020

Website

https://www.brightgreen.us

Bright Green Corp is a provider of cannabis, cannabis-related products, and other legal medicinal plant-based therapies, manufactured for research and pharmaceutical applications, as well as being an active ingredient in consumer-based solutions. The company plans to focus on the development of cannabis strains and sales of products with high contents of CBN (cannabinol) and CBG (cannabigerol).

Executives

Gurvinder Singh	officer: Chief Executive Officer	1033 GEORGE HANOSH BOULEVARD, GRANTS NM 87020
Saleem Elmasri	officer: Chief Financial Officer	450 PARK AVE SOUTH, 3RD FLOOR, NEW YORK NY 10016
Lynn Stockwell	director, 10 percent owner	401 EAST LAS OLAS BLVD., SUITE 1400, FT. LAUDERDALE FL 33301
Seamus Mcauley	officer: Chief Executive Officer	1033 GEORGE HANOSH BOULEVARD, GRANTS NM 87020
Edward A. Robinson	director, officer: Chief Executive Officer	401 EAST LAS OLAS BLVD., SUITE 1400, FT. LAUDERDALE FL 33301
Alfie Morgan	director	401 EAST LAS OLAS BLVD., SUITE 1400, FT. LAUDERDALE FL 33301
Dean Vallore	director	401 EAST LAS OLAS BLVD., SUITE 1400, FT. LAUDERDALE FL 33301
Terry Rafih	director, 10 percent owner	401 EAST LAS OLAS BLVD., SUITE 1400, FT. LAUDERDALE FL 33301
Robert Arnone	director	401 EAST LAS OLAS BLVD., SUITE 1400, FT. LAUDERDALE FL 33301
E. Mailloux Enterprises, Inc.	10 percent owner	3129 MARENTETTE AVENUE, UNIT 2, WINDSOR A6 N8X 4G1